Open Access

MicroRNA-218 inhibits the proliferation and metastasis of esophageal squamous cell carcinoma cells by targeting BMI1

Corrigendum in: /10.3892/ijmm.2023.5269

  • Authors:
    • Ting Wang
    • Tengfei Chen
    • Hua Niu
    • Chang Li
    • Chun Xu
    • Yuanyuan Li
    • Rui Huang
    • Jun Zhao
    • Shuyan Wu
  • View Affiliations

  • Published online on: May 21, 2015     https://doi.org/10.3892/ijmm.2015.2216
  • Pages: 93-102
  • Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

MicroRNAs (miRNAs or miRs) play a pivotal role in esophageal carcinogenesis either as oncogenes or as tumor suppressor genes. In the present study, we found that the expression level of miR-218 was significantly reduced in esophageal squamous cell carcinoma (ESCC) tissues and ESCC cell lines. Moreover, its expression was found to correlate with the clinicopathological stage of ESCC; miR-218 expression was lower in the stage III tissue samples than in the stage I and II tissue samples. Furthermore, the decreased expression of miR-218 was found to be associated with an enhanced ESCC cell proliferation and metastasis. Western blot analysis and luciferase reporter assay revealed that miR-218 decreased BMI1 expression by binding to the putative binding sites in its 3'-untranslated region (3'-UTR). The BMI1 mRNA expression levels were markedly increased and negatively correlated with the miR-218 expression level in the ESCC tissues. Functional analyses revealed that the restoration of miR-218 expression inhibited ESCC cell proliferation, migration and invasion and promoted apoptosis. The knockdown of BMI1 by siRNA showed the same phenocopy as the effect of miR-218 on ESCC cells, indicating that BMI1 was a major target of miR-218. In the present study, our findings confirm miR-218 as a tumor suppressor and identify BMI1 as a novel target of miR-218 in ESCC. Therefore, miR-218 may prove to be a useful biomarker for monitoring the initiation and development of ESCC, and may thus be an effective therapeutic target in ESCC.
View Figures
View References

Related Articles

Journal Cover

July-2015
Volume 36 Issue 1

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Wang T, Chen T, Niu H, Li C, Xu C, Li Y, Huang R, Zhao J and Wu S: MicroRNA-218 inhibits the proliferation and metastasis of esophageal squamous cell carcinoma cells by targeting BMI1 Corrigendum in /10.3892/ijmm.2023.5269. Int J Mol Med 36: 93-102, 2015.
APA
Wang, T., Chen, T., Niu, H., Li, C., Xu, C., Li, Y. ... Wu, S. (2015). MicroRNA-218 inhibits the proliferation and metastasis of esophageal squamous cell carcinoma cells by targeting BMI1 Corrigendum in /10.3892/ijmm.2023.5269. International Journal of Molecular Medicine, 36, 93-102. https://doi.org/10.3892/ijmm.2015.2216
MLA
Wang, T., Chen, T., Niu, H., Li, C., Xu, C., Li, Y., Huang, R., Zhao, J., Wu, S."MicroRNA-218 inhibits the proliferation and metastasis of esophageal squamous cell carcinoma cells by targeting BMI1 Corrigendum in /10.3892/ijmm.2023.5269". International Journal of Molecular Medicine 36.1 (2015): 93-102.
Chicago
Wang, T., Chen, T., Niu, H., Li, C., Xu, C., Li, Y., Huang, R., Zhao, J., Wu, S."MicroRNA-218 inhibits the proliferation and metastasis of esophageal squamous cell carcinoma cells by targeting BMI1 Corrigendum in /10.3892/ijmm.2023.5269". International Journal of Molecular Medicine 36, no. 1 (2015): 93-102. https://doi.org/10.3892/ijmm.2015.2216